Wednesday, October 19, 2011: 10:00 AM-1:00 PM
Chairs:
9.1
Developmental Neuroscience and Treatment Studies: Identifying Windows of New Opportunity
Cecile D. Ladouceur, Ph.D.
University of Pittsburgh School of Medicine, Pittsburgh, PA
9.2
Neuroimaging and Psychotherapy Mechanisms of Change for Adolescent Addictive Behaviors
Sarah W. Feldstein Ewing, Ph.D.
The Mind Research Network, Albuquerque, NM
9.3
Vulnerabilities to Addictive Behaviors in Adolescents: Neural Systems Mechanisms as Targets for Treatment
Monique Ernst, M.D.
National Institutes of Health, National Institute of Mental Health, Bethesda, MD
Daniel Pine, M.D.
National Institute of Mental Health, Bethesda, MD
Amanda E. Guyer, Ph.D.
University of California, Davis, Davis, CA
Michael G. Hardin, Ph.D.
Stanford University, Stanford, CA
Jennifer Lau, Ph.D.
University of Oxford, Magdalen College, Oxford United Kingdom
Johanna Jarcho, Ph.D.
National Institute of Mental Health, Bethesda, MD
9.4
Neuroeconomics and Adolescent Substance Abuse: Neural Activity and Preference for Immediate Rewards among Treated Teens
Catherine Stanger, Ph.D.
University of Arkansas for Medical Sciences, Little Rock, AR
Stacy R. Ryan, Ph.D.
University of Arkansas for Medical Sciences, Little Rock, AR
9.5
Using fMRI to Examine Reward Sensitivity and Treatment Response for Smoking Among Youths
Laura MacPherson, Ph.D.
The University of Maryland, College Park, College Park, MD
Anahi Collado-Rodriguez, B.A.
University of Maryland, College Park, College Park, MD
Kathy Geisel, B.A.
University of Maryland, College Park, College Park, MD
Carl W. Lejuez, Ph.D.
University of Maryland, College Park, College Park, MD
Marc N. Potenza, M.D., Ph.D.
Yale School of Medicine, New Haven, CT
Linda C. Mayes, M.D.
Yale Child Study Center, New Haven, CT
Suchitra Krishnan-Sarin, Ph.D.
Yale School of Medicine, New Haven, CT
Monique Ernst, M.D.
National Institutes of Health, National Institute of Mental Health, Bethesda, MD
Partially supported by an educational grant from the
National Institute on Drug Abuse